FRESENIUS MEDICAL CARE HOLDINGS INC: $34.9M Department of Veterans Affairs Contract
Summary
Fresenius Medical Care (FMS) received a $34.9M delivery order from the VA for dialysis services in February 2026. This is a routine, recurring contract under an existing framework, representing ~0.2% of FMS's annual revenue. No material stock impact expected.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Routine $34.9M monthly VA dialysis delivery order for Fresenius Medical Care (FMS).
- 2.Represents ~0.2% of FMS annual revenue — not material.
- 3.No related legislation directly impacts this contract.
- 4.No significant stock catalyst expected from this award.
Market Implications
This contract is a non-event for FMS stock. The company's government dialysis revenue is well-understood by investors and is a small, stable portion of total revenue. FMS shares are driven by commercial dialysis volume, Medicare reimbursement rates, and operational efficiency, not by routine VA orders. No other publicly traded companies are materially affected.
Full Analysis
The Department of Veterans Affairs awarded Fresenius Medical Care Holdings Inc. a $34.9M delivery order under the FY26 February NDSC Express Report. This is a standard monthly procurement under the National Dialysis Services Contract (NDSC), which provides dialysis care to eligible veterans. The contract covers the one-month period of February 2026.
Fresenius Medical Care Holdings Inc. is the U.S. operating subsidiary of Fresenius Medical Care AG & Co. KGaA (NYSE: FMS), a German multinational with approximately $20B in annual revenue. This $34.9M award represents roughly 0.2% of annual revenue — a routine, predictable payment that does not alter the company's financial trajectory. FMS is the dominant provider of dialysis services to the VA, and such monthly orders are standard under the multi-year NDSC framework.
No related bill signals directly authorize or appropriate this specific contract. The VA's dialysis program is funded through annual appropriations for veterans' healthcare, not through any of the listed bills. The bills shown (e.g., HR8500 on Medicare coverage, HR8375 on Medicare Advantage) are neutral to this contract as they focus on Medicare, not VA healthcare.
Downstream supply chain beneficiaries are limited, as FMS is vertically integrated in dialysis. However, smaller suppliers of dialysis consumables (e.g., dialyzers, tubing sets) could see indirect benefit. Private companies like NxStage (a Fresenius subsidiary) or publicly traded Baxter International (BAX) in the broader dialysis supply chain may see minor, unquantifiable spillover demand.
Historically, VA dialysis contracts are stable, recurring revenue streams for FMS. They do not cause stock price movements because they are expected and priced into the company's government segment. The stock is more sensitive to changes in Medicare reimbursement rates, patient volume trends, and regulatory actions on dialysis payment models.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Direct award of a delivery order for dialysis services or supplies to Fresenius Medical Care Holdings Inc., the U.S. subsidiary of Fresenius Medical Care AG & Co. KGaA.
Who must act
Department of Veterans Affairs awarding to Fresenius Medical Care Holdings Inc.
What happens
$34.9M added to February 2026 revenue, representing approximately 0.2% of Fresenius Medical Care's annual revenue (~$20B).
Stock impact
Fresenius Medical Care is the world's largest provider of dialysis services and products. This VA contract is a routine monthly delivery order under an existing NDSC (National Dialysis Services Contract) framework, providing predictable, recurring revenue from the federal government. It reinforces FMS's dominant position in the VA dialysis market but is not transformative given the company's scale.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
MERCK SHARP & DOHME LLC: $2.4B Department of Health and Human Services Contract Vehicle
PA DEPARTMENT OF HUMAN SERVICES: $1.0B Department of Health and Human Services Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $1.5B Department of Homeland Security Grant
HUMAN SERVICES, NEW JERSEY DEPARTMENT OF: $16.9B Department of Health and Human Services Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $2.9B Department of Homeland Security Grant
GOVERNOR'S AUTHORIZED REPRESENTATIVE: $1.8B Department of Homeland Security Grant
DEPARTMENT OF SOCIAL SERVICES MISSO: $15.1B Department of Health and Human Services Grant
MINNESOTA DEPARTMENT OF HUMAN SERVICES: $14.1B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Contract Details
Recipient
FRESENIUS MEDICAL CARE HOLDINGS INC
Award Amount
$34,917,899
Awarding Agency
Department of Veterans Affairs
Sub-Agency
Department of Veterans Affairs
Contract Type
DELIVERY ORDER
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →